Role of protein tyrosine phosphatases in regulating the immune system: Implications for chronic intestinal inflammation

Inflammatory Bowel Diseases

Volumn 21, Issue 3, 2015, Pages 645-655

  Spalinger, Marianne R ^a   McCole, Declan F ^b   Rogler, Gerhard ^a,c   Scharl, Michael ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

PTPN11 and IBD; PTPN2 and IBD; PTPN22 and IBD

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ADAPTIVE IMMUNITY; ARTICLE; AUTOPHAGOSOME; BONE MARROW CELL; CHRONIC INTESTINAL INFLAMMATION; CYTOKINE RELEASE; EXPERIMENTAL COLITIS; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; LYMPHOCYTE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CHRONIC DISEASE; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; INTESTINE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; CHRONIC DISEASE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTESTINES; MICE; PROTEIN TYROSINE PHOSPHATASES;

EID: 84923406514     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000297     Document Type: Article

References (93)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448: 427-434.
2. Lees CW, Barrett JC, Parkes M, et al. New IBD genetics: common pathways with other diseases. Gut. 2011; 60: 1739-1753.
3. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. 2006; 7: 833-846.
4. Diaz-Gallo LM, Espino-Paisan L, Fransen K, et al. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2011; 17: 2287-2294.
5. Kyogoku C, Langefeld CD, Ortmann WA, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet. 2004; 75: 504-507.
6. Michou L, Lasbleiz S, Rat AC, et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U.S.A. 2007; 104: 1649-1654.
7. Begovich AB, Carlton VE, Honigberg LA, et al. A missense singlenucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004; 75: 330-337.
8. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36: 337-338.
9. Stanford SM, Bottini N. PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol. 2014; 10: 602-611.
10. Orru V, Tsai SJ, Rueda B, et al. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet. 2009; 18: 569-579.
11. Rodríguez-Rodríguez L, Taib WRW, Topless R, et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum. 2011; 63: 365-372.
12. Vang T, Congia M, Macis MD, et al. Autoimmune-Associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet. 2005; 37: 1317-1319.
13. Yu X, Sun JP, He Y, et al. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc Natl Acad Sci U S A. 2007; 104: 19767-19772.
14. Fiorillo E, Orru V, Stanford SM, et al. Autoimmune-Associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem. 2010; 285: 26506-26518.
15. Zhang J, Zahir N, Jiang Q, et al. The autoimmune disease-Associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet. 2011; 43: 902-907.
16. Dai X, James RG, Habib T, et al. A disease-Associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest. 2013; 123: 2024-2036.
17. Zheng P, Kissler S. PTPN22 silencing in the NOD model indicates the type 1 diabetes-Associated allele is not a loss-of-function variant. Diabetes. 2013; 62: 896-904.
18. Wang Y, Shaked I, Stanford SM, et al. The autoimmunity-Associated gene PTPN22 potentiates Toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity. 2013; 39: 111-122.
19. Arimura Y, Yagi J. Comprehensive expression profiles of genes for protein tyrosine phosphatases in immune cells. Sci Signal. 2010; 3: rs1.
20. Gjorloff-Wingren A, Saxena M, Williams S, et al. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol. 1999; 29: 3845-3854.
21. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med. 1999; 189: 111-121.
22. Hasegawa K, Martin F, Huang G, et al. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science. 2004; 303: 685-689.
23. Brownlie RJ, Miosge LA, Vassilakos D, et al. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci Signal. 2012; 5: ra87.
24. Menard L, Saadoun D, Isnardi I, et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest. 2011; 121: 3635-3644.
25. Habib T, Funk A, Rieck M, et al. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol. 2012; 188: 487-496.
26. Maine CJ, Marquardt K, Cheung J, et al. PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells. J Immunol. 2014; 192: 1415-1424.
27. Spalinger MR, Lang S, Weber A, et al. Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-gamma-induced signaling in human monocytes. Gastroenterology. 2013; 144: 978 e910-988 e910.
28. Chang HH, Miaw SC, Tseng W, et al. PTPN22 modulates macrophage polarization and susceptibility to dextran sulfate sodium-induced colitis. J Immunol. 2013; 191: 2134-2143.
29. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-Analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010; 42: 1118-1125.
30. Salmond RJ, Brownlie RJ, Morrison VL, et al. The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals. Nat Immunol. 2014; 15: 875-883.
31. Cool DE, Tonks NK, Charbonneau H, et al. cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. Proc Natl Acad Sci U S A. 1989; 86: 5257-5261.
32. Tiganis T, Bennett AM. Protein tyrosine phosphatase function: the substrate perspective. Biochem J. 2007; 402: 1-15.
33. Lorenzen JA, Dadabay CY, Fischer EH. COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol. 1995; 131: 631-643.
34. Ibarra-Sanchez MJ, Simoncic PD, Nestel FR, et al. The T-cell protein tyrosine phosphatase. Semin Immunol. 2000; 12: 379-386.
35. Tiganis T. PTP1B and TCPTP-nonredundant phosphatases in insulin signaling and glucose homeostasis. FEBS J. 2013; 280: 445-458.
36. Galic S, Hauser C, Kahn BB, et al. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol. 2005; 25: 819-829.
37. Tiganis T, Bennett AM, Ravichandran KS, et al. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol. 1998; 18: 1622-1634.
38. Mattila E, Pellinen T, Nevo J, et al. Negative regulation of EGFR signaling through integrin-Alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol. 2005; 7: 78-85.
39. van Vliet C, Bukczynska PE, Puryer MA, et al. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol. 2005; 6: 253-260.
40. ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol. 2002; 22: 5662-5668.
41. Simoncic PD, Lee-Loy A, Barber DL, et al. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 2 Curr Biol. 2002; 12: 446-453.
42. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007; 39: 857-864.
43. Anderson CA, Boucher G, Lees CW, et al. Meta-Analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to. Nat Genet. 2011; 43: 246-252.
44. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008; 359: 2767-2777.
45. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-678.
46. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007; 39: 830-832.
47. Franke A, Balschun T, Karlsen TH, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008; 40: 713-715.
48. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
49. Weersma RK, Stokkers PC, Cleynen I, et al. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol. 2009; 104: 630-638.
50. Waterman M, Xu W, Stempak JM, et al. Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011; 17: 1936-1942.
51. Glas J, Wagner J, Seiderer J, et al. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background. PLoS One. 2012; 7: e33682.
52. Amre DK, Mack DR, Morgan K, et al. Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children. Aliment Pharmacol Ther. 2010; 31: 1186-1191.
53. Scharl M, Mwinyi J, Fischbeck A, et al. Crohn's disease-Associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflamm Bowel Dis. 2012; 18: 900-912.
54. Scharl M, Paul G, Weber A, et al. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2. Gastroenterology. 2009; 137: 2030 e2035-2040 e2035.
55. Scharl M, McCole DF, Weber A, et al. Protein tyrosine phosphatase N2 regulates TNFa-induced signaling and cytokine secretion in human intestinal epithelial cells. Gut. 2011; 60: 189-197.
56. Marcil V, Mack DR, Kumar V, et al. Association between the PTPN2 gene and Crohn's disease: dissection of potential causal variants. Inflamm Bowel Dis. 2013; 19: 1149-1155.
57. Yu W, Hegarty JP, Berg A, et al. PTPN2 is associated with Crohn's disease and its expression is regulated by NKX2-3. Dis Markers. 2012; 32: 83-91.
58. Zeissig S, Burgel N, Gunzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut. 2007; 56: 61-72.
59. Weber CR, Raleigh DR, Su L, et al. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem. 2010; 285: 12037-12046.
60. McCole DF. Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2. Ann N Y Acad Sci. 2012; 1257: 108-114.
61. You-Ten KE, Muise ES, Itie A, et al. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatasedeficient mice. J Exp Med. 1997; 186: 683-693.
62. Wiede F, Chew SH, van Vliet C, et al. Strain-dependent differences in bone development, myeloid hyperplasia, morbidity and mortality in ptpn2-deficient mice. PLoS One. 2012; 7: e36703.
63. Heinonen KM, Nestel FP, Newell EW, et al. T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood. 2004; 103: 3457-3464.
64. Hassan SW, Doody KM, Hardy S, et al. Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse. PLoS One. 2010; 5: e8868.
65. McCole DF, Barrett KE. Varied role of the gut epithelium in mucosal homeostasis. Curr Opinion Gastroenterol. 2007; 23: 647-654.
66. Greig ER, Boot-Handford RP, Mani V, et al. Decreased expression of apical Na+ channels and basolateral Na+, K+-ATPase in ulcerative colitis. J Pathol. 2004; 204: 84-92.
67. Sugi K, Musch MW, Field M, et al. Inhibition of Na+, K+-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function. Gastroenterology. 2001; 120: 1393-1403.
68. Xiao F, Juric M, Li J, et al. Loss of downregulated in adenoma (DRA) impairs mucosal HCO3(-) secretion in murine ileocolonic inflammation. Inflamm Bowel Dis. 2012; 18: 101-111.
69. Scharl M, Rudenko I, McCole DF. Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion. Am J Physiol Gastrointest Liver Physiol. 2010; 299: G935-G945.
70. Wiede F, Shields BJ, Chew SH, et al. T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Invest. 2011; 121: 4758-4774.
71. Scharl M, Hruz P, McCole DF. Protein tyrosine phosphatase non-receptor Type 2 regulates IFN-g-induced cytokine signaling in THP-1 monocytes. Inflamm Bowel Dis. 2010; 16: 2055-2064.
72. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol. 2007; 7: 767-777.
73. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol. 2001; 2: 211-216.
74. Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008; 451: 1069-1075.
75. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132: 27-42.
76. Birmingham CL, Canadien V, Gouin E, et al. Listeria monocytogenes evades killing by autophagy during colonization of host cells. Autophagy. 2007; 3: 442-451.
77. Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and NOD2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010; 11: 55-62.
78. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010; 16: 90-97.
79. Scharl M, Wojtal KA, Becker HM, et al. Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm Bowel Dis. 2012; 18: 1287-1302.
80. Maiuri MC, Zalckvar E, Kimchi A, et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007; 8: 741-752.
81. Miyasaka H, Li SS. Molecular cloning, nucleotide sequence and expression of a cDNA encoding an intracellular protein tyrosine phosphatase, PTPase-2, from mouse testis and T-cells. Mol Cellular Biochemistry. 1992; 118: 91-98.
82. Johnson CV, Cool DE, Glaccum MB, et al. Isolation and mapping of human T-cell protein tyrosine phosphatase sequences: localization of genes and pseudogenes discriminated using fluorescence hybridization with genomic versus cDNA probes. Genomics. 1993; 16: 619-629.
83. Doody KM, Bourdeau A, Tremblay ML. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunol Rev. 2009; 228: 325-341.
84. Bourdeau A, Dube N, Heinonen KM, et al. TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}. Blood. 2007; 109: 4220-4228.
85. Wiede F, Ziegler A, Zehn D, et al. PTPN2 restrains CD8(+) T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice. J Autoimmun. 2014; 53: 105-114.
86. Wiede F, La Gruta NL, Tiganis T. PTPN2 attenuates T-cell lymphopeniainduced proliferation. Nat Commun. 2014; 5: 3073.
87. Zhang J, Wang B, Zhang W, et al. Protein tyrosine phosphatase 1B deficiency ameliorates murine experimental colitis via the expansion of myeloid-derived suppressor cells. PLoS One. 2013; 8: e70828.
88. Bouzid D, Fourati H, Amouri A, et al. Association of ZAP70 and PTPN6, but Not BANK1 or CLEC2D, with inflammatory bowel disease in the Tunisian population. Genet Test Mol Biomarkers. 2013; 17: 321-326.
89. Mauldin IS, Tung KS, Lorenz UM. The tyrosine phosphatase SHP-1 dampens murine Th17 development. Blood. 2012; 119: 4419-4429.
90. Narumi Y, Isomoto H, Shiota M, et al. Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population. J Clin Immunol. 2009; 29: 303-310.
91. Coulombe G, Leblanc C, Cagnol S, et al. Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice. Mol Cell Biol. 2013; 33: 2275-2284.
92. Wu X, Guo W, Wu L, et al. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis. J Immunol. 2012; 189: 3497-3507.
93. Yamashita H, Kotani T, Park JH, et al. Role of the protein tyrosine phosphatase Shp2 in homeostasis of the intestinal epithelium. PLoS One. 2014; 9: e92904.